Abstract | BACKGROUND:
Tetracycline is a commonly used drug for rosacea and subantimicrobial doses may resolve the disease in many cases. Although this class of antibiotics has been linked to adverse effects, tetracycline is considered a safe drug. It can be associated with hepatotoxicity, but its role in these rare cases is unclear. PURPOSE: To report the case of a patient with rare tetracycline-induced hepatotoxicity. CASE PRESENTATION: CONCLUSIONS: The dose-dependency of rare tetracycline hepatotoxicity and the desire to reduce antibiotic resistance may prompt safe, yet effective, subantimicrobial doses for rosacea.
|
Authors | Candace Glenn, Steven R Feldman |
Journal | Dermatology online journal
(Dermatol Online J)
Vol. 17
Issue 12
Pg. 14
(Dec 15 2011)
ISSN: 1087-2108 [Electronic] United States |
PMID | 22233750
(Publication Type: Letter)
|
Chemical References |
- Anti-Bacterial Agents
- Tetracycline
|
Topics |
- Anti-Bacterial Agents
(adverse effects)
- Chemical and Drug Induced Liver Injury
(diagnosis)
- Female
- Humans
- Liver
(drug effects)
- Liver Function Tests
- Middle Aged
- Rosacea
(drug therapy)
- Tetracycline
(adverse effects)
- Treatment Outcome
- Withholding Treatment
|